| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Valor IV Pharma Holdings, LLC last filed a Form 4 in August 2025, as 10% Owner at HRMY.
Valor IV Pharma Holdings, LLC has 3 Form 4 filings on record from August 2020 to August 2025, all as 10% Owner at Harmony Biosciences (HRMY), 2020–2025.
The 5 reported transactions were 2 open-market sales, 2 conversions and 1 other transaction.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $139.4M.
The only open-market sale was 4,600,000 shares of HRMY at an average $30.30 on November 5, 2024, about $139.4M. Twelve months later HRMY was down 6%.
Shares as reported in the last Form 4 for each company; the most recent is from August 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2024 | HRMY Harmony Biosciences Holdings, Inc. | 10% Owner | Sell | 4,600,000 | $30.30 | $139,391,500.00 | -41.0% | +15.8% | -6.2% |